NANCY FELTNER: Open Payments
NPI 1437548070 · WOODBURN, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 55 payments from 8 companies in 2025. Trend: 2023 $421 · 2024 $647 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $328 |
| Otsuka America Pharmaceutical, Inc. | 9 | $169 |
| Supernus Pharmaceuticals, Inc. | 10 | $145 |
| Lundbeck LLC | 4 | $78 |
| E.R. Squibb & Sons, L.L.C. | 2 | $69 |
| Exact Sciences Corporation | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: VRAYLAR, REXULTI, Qelbree, ABILIFY MAINTENA, COBENFY, The Cologuard Plus Collection Kit, UZEDY, ABILIFY ASIMTUFII.
Industry payments across OR — which companies pay providers there.
